Ampio Pharmaceuticals, Inc. (AMPE)

OTCMKTS · Delayed Price · Currency is USD
0.2926
+0.0014 (0.46%)
Mar 4, 2026, 4:00 PM EST
Market Cap332.15K -76.1%
Revenue (ttm)n/a
Net Income-8.63M
EPS-10.66
Shares Out1.14M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume334
Average Volume1,423
Open0.0052
Previous Close0.2912
Day's Range0.0052 - 0.2926
52-Week Range0.0001 - 0.2926
Beta6.62
RSI66.88
Earnings Daten/a

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Michael Martino
Employees 6
Stock Exchange OTCMKTS
Ticker Symbol AMPE
Full Company Profile

Financial Performance

Financial Statements